Moreover, knockdown (KD) of CPEB4 promoted tumorigenesis of HepG2 cells in a subcutaneous-injection xenograph mouse model, which was opposite to findings in RWP-1 cells, derived from moderately to well-differentiated PDA [26]. This evidence concerns the gene CPEB4 and Patent ductus arteriosus.